Inventiva (IVA) EPS (Weighted Average and Diluted) (2019 - 2021)
Inventiva (IVA) recorded quarterly EPS (Weighted Average and Diluted) of -$0.22 in Q2 2021, down 34.39% quarter-over-quarter from -$0.16 in Q1 2021, and up 3.3% on a YoY basis from -$0.21 in Q2 2020.
Inventiva (IVA) EPS (Weighted Average and Diluted) (2019 - 2021) Analysis & Trends
Inventiva's EPS (Weighted Average and Diluted) history runs 3 years deep, the most recent figure standing at -$0.22 for Q2 2021.
- In Q2 2021, EPS (Weighted Average and Diluted) rose 3.3% year-over-year to -$0.22; the TTM figure through Jun 2022 stood at -$23218.1 (down 10572194.6% YoY), while the FY2025 annual figure was -$2.21, up 32.8% from the prior year.
- EPS (Weighted Average and Diluted) was -$0.22 for Q2 2021 at Inventiva, down from -$0.16 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.16 in Q1 2021 to a low of -$1.28 in Q4 2019.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.5 across 3 years, with a median of -$0.23 in 2020.
- The sharpest annual moves came in 2020 and 2021: EPS (Weighted Average and Diluted) surged 31.54% in 2020, then gained 3.3% in 2021.
- A 3-year view of EPS (Weighted Average and Diluted) shows it stood at -$1.28 in 2019, then soared by 31.54% to -$0.88 in 2020, then jumped by 74.98% to -$0.22 in 2021.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.22 (Q2 2021), -$0.16 (Q1 2021), and -$0.88 (Q4 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 0.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -0.61 |
| 10 | Inventiva | 8.93 Mn | -259.80 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -0.22 |
| Mar 31, 2021 | -0.16 |
| Dec 31, 2020 | -0.88 |
| Jun 30, 2020 | -0.23 |
| Mar 31, 2020 | -0.23 |
| Dec 31, 2019 | -1.28 |